Abstract
A greater susceptibility to the adverse effects of protease inhibitors is just one of many possible reasons highly active antiretroviral therapy has been less beneficial to women. Consider the obstacles and how you can help patients overcome them.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 32-39 |
| Number of pages | 8 |
| Journal | IM - Internal Medicine |
| Volume | 20 |
| Issue number | 1 |
| State | Published - Jan 1 1999 |
ASJC Scopus subject areas
- Internal Medicine
